Viridian Therapeutic (VRDN) PT Lowered to $37 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts VRDN Hot Sheet
Price: $21.24 -4.71%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $37.00 (from $40.00) while maintaining a Buy rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Oracle (ORCL) PT Lowered to $200 at Stifel, Buy Rating Maintained
- Jazz Pharmaceuticals (JAZZ) PT Raised to $337 at UBS on GEA Approval for Ziihera
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
